Matinas BioPharma Inc.

AMEX: MTNB · Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT

Matinas BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
962K 962K -1.1M -1.1M -1.1M n/a 2.16M 3.22M 4.28M 3.19M 2.09M 1.03M -33.3K 33.00 95.83K 191.67K 191.67K
Cost of Revenue
241K 481K 721K 959K 952K 941K 4.19M 4.18M 4.18M 4.16M 2M 1.97M 1.92M 4.95M 4.69M 7.83M 11.06M
Gross Profit
-241K -481K -1.82M -2.06M -2.05M -941K -2.03M -963.29K 103.35K -975.18K 91.52K -936.23K -1.95M -4.95M -4.6M -7.64M -10.87M
Operating Income
-16.2M -20.16M -22.01M -23.76M -24.08M -23.77M -23.36M -22.69M -22.45M -24.59M -25.82M -27.24M -26.1M -24.73M -24.51M -23.24M -24.21M
Interest Income
n/a n/a n/a n/a 1K 1K 1K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-20.16M -24.33M -21.13M -22.91M -23.25M -22.94M -21.26M -20.67M -20.53M -21M -24.06M -25.44M -24.31M -23.28M -22.92M -21.54M -22.36M
Net Income
-20.08M -24.25M -21.13M -22.91M -23.25M -22.87M -17.59M -16.99M -16.85M -13.91M -20.58M -21.96M -20.83M -23.28M -22.92M -21.54M -22.36M
Selling & General & Admin
8.13M 8.49M 8.81M 9.51M 9.64M 10.13M 10.83M 10.81M 11.07M 11.1M 10.9M 10.34M 9.78M 10.18M 10.74M 10.84M 10.89M
Research & Development
8.07M 11.43M 12.72M 13.78M 13.96M 14.49M 14.69M 15.1M 15.67M 16.68M 17.05M 17.97M 16.32M 14.58M 13.87M 12.58M 13.51M
Other Expenses
n/a n/a n/a 79K 178K 251K 339.25K 261.24K 165.11K 102K 28.32K 68.73K 64.44K 122.87K 256.3K 370K 527.42K
Operating Expenses
15.96M 19.67M 21.53M 23.28M 23.6M 24.62M 25.52M 25.91M 26.74M 27.78M 27.95M 28.3M 26.1M 24.77M 24.61M 23.43M 24.4M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -240K -480K -480K -480K -240K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
20.64M 24.59M 22.01M 23.76M 24.08M 24.86M 25.52M 25.91M 26.74M 27.78M 27.95M 28.3M 26.1M 24.77M 24.61M 23.43M 24.4M
Income Tax Expense
-80K -80K n/a n/a n/a -73K -3.67M -3.68M -3.68M -7.08M -3.48M -3.48M -3.48M n/a n/a n/a n/a
Shares Outstanding (Basic)
5.09M 4.87M 5.04M 4.99M 4.35M 4.35M 4.35M 4.35M 4.35M 4.34M 4.34M 4.34M 4.33M 4.33M 4.3M 4.1M 4.08M
Shares Outstanding (Diluted)
5.09M 4.87M 5.04M 4.99M 4.35M 4.35M 4.35M 4.35M 4.35M 4.34M 4.34M 4.34M 4.33M 4.33M 4.3M 4.1M 4.08M
EPS (Basic)
-4.06 -5.07 -4.56 -5.1 -5.34 -5.25 -4.04 -3.91 -3.88 -3.21 -4.75 -5.08 -4.89 -5.53 -5.57 -5.42 -5.67
EPS (Diluted)
-4.06 -5.07 -4.56 -5.1 -5.34 -5.25 -4.04 -3.91 -3.88 -3.21 -4.75 -5.08 -4.89 -5.53 -5.57 -5.35 -5.6
EBITDA
-15.47M -19.19M -21.1M -22.86M -23.09M -22.71M -22.39M -21.72M -21.59M -23.95M -25.06M -26.47M -25.39M -24.03M -23.68M -22.58M -23.38M
EBIT
-14.26M -20.16M -22.01M -23.76M -24.08M -23.77M -23.36M -22.69M -22.45M -24.59M -25.82M -27.24M -26.1M -24.73M -24.51M -23.24M -24.21M
Depreciation & Amortization
732K 972K 965K 959K 952K 941K 926.82K 919.61K 915.47K 898K 877.29K 842.54K 795.46K 781.49K 767.33K 759.91K 773.69K